CTLA4 and neoplasm: PDT treatment has the ability to activate the tumor‐specific immune responses by producing tumor‐associated antigens from tumor cell residues, which afterward may be processed by APCs such as DCs and then presented to T cells. PDT combined with CTLA‐4 blockade would effectively induce the generation of TEM‐based immune memory response to prevent tumor relapse.